Novabridge Biosciences 6-K Filing
Ticker: NBP · Form: 6-K · Filed: Dec 4, 2025 · CIK: 1778016
Sentiment: neutral
Filing Stats: 175 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2025-12-04 07:06:36
Filing Documents
- pr_-_esmo_io_abstract_-_.htm (6-K) — 27KB
- nbp-ex99_1.htm (EX-99.1) — 37KB
- img62529193_0.jpg (GRAPHIC) — 440KB
- 0001193125-25-307454.txt ( ) — 672KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. I-MAB By : /s/ Xi-Yong Fu Name : Xi-Yong (Sean) Fu Title : Chief Executive Officer Date: December 4, 2025